Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections (Q43996924)

28 November 2017

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections (English)

1 reference

methicillin-resistant Staphylococcus aureus

28 November 2017

0 references

1 reference

1 reference

Staphylococcus aureus

object named as

Staphylococcus aureus

1 reference

Dennis L Stevens

1

1 reference

28 November 2017

Daniel Herr

2

1 reference

28 November 2017

Harry Lampiris

3

1 reference

28 November 2017

John Lee Hunt

4

1 reference

28 November 2017

Donald H Batts

5

1 reference

28 November 2017

Barry Hafkin

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

13 May 2002

1 reference

Clinical Infectious Diseases

28 November 2017

1 reference

28 November 2017

34

1 reference

28 November 2017

1481-1490

1 reference

28 November 2017

11

1 reference

Epidemiology of methicillin-resistant Staphylococcus aureus

28 November 2017

1 reference

Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk

21 January 2018

1 reference

Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children.

21 January 2018

1 reference

Antimicrobial resistance in staphylococci. Epidemiology, molecular mechanisms, and clinical relevance

21 January 2018

1 reference

Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance Group.

21 January 2018

1 reference

Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci

21 January 2018

1 reference

The economic impact of Staphylococcus aureus infection in New York City hospitals

21 January 2018

1 reference

Comparison of length of hospital stay for patients with known or suspected methicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin: a randomized, multicenter trial

21 January 2018

1 reference

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

21 January 2018

1 reference

Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin.

21 January 2018

1 reference

Low-level teicoplanin resistance and heteroresistance to vancomycin.

21 January 2018

1 reference

The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.

21 January 2018

1 reference

Bacteremia caused by staphylococci with inducible vancomycin heteroresistance.

21 January 2018

1 reference

Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections

21 January 2018

1 reference

Ribosomal RNA is the target for oxazolidinones, a novel class of translational inhibitors

21 January 2018

1 reference

Linezolid absolute bioavailability and the effect of food on oral bioavailability

21 January 2018

1 reference

Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections

21 January 2018

1 reference

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

21 January 2018

1 reference

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

21 January 2018

1 reference

Linezolid resistance in a clinical isolate of Staphylococcus aureus

21 January 2018

1 reference

Overview of resistance in the 1990s

21 January 2018

1 reference

Bird's-eye view of nosocomial infections in medical ICU: blue bugs, fungi, and device-days.

21 January 2018

1 reference

Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/340353

1 reference

28 November 2017

1 reference